tirzepatide for the treatment of obstructive sleep apnea and obesity Why is Zepbound used Apnea? Zepbound® (tirzepatide) is approved for obstructive sleep (OSA) because it targets one most important underlying causes of the condition: obesity. OSA Tirzepatide in Obesity-Related Obstructive Sleep
Pay in 4 interest-free payments of $6.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 16 - Nov 21



























